What is the recommended duration of Augmentin (amoxicillin/clavulanate) therapy for her?

Duration of Augmentin Therapy

For children with acute bacterial rhinosinusitis (ABRS), prescribe Augmentin for 10-14 days; for adults with uncomplicated ABRS, prescribe for 5-7 days. 1, 2

Treatment Duration by Age Group

Children (Pediatric Patients)

• 10-14 days is the recommended duration for children with ABRS 1
• The FDA label for Augmentin ES-600 specifically indicates 10 days of treatment for pediatric patients 3 months and older 3
• This longer duration in children is supported by weak to low-moderate quality evidence but remains the standard recommendation 1

Adults

• 5-7 days is sufficient for uncomplicated ABRS in adults 1
• The 2015 AAO-HNS guideline supports 5-10 days as an acceptable range 2
• Shorter courses (5 days) have been shown equally effective as longer courses (7 days) in adults with acute exacerbations of chronic bronchitis 4

Key Clinical Considerations

Dosing matters as much as duration:

• Children require high-dose amoxicillin-clavulanate: 90 mg/kg/day divided twice daily 1, 3
• Adults should receive 2g orally twice daily for high-dose therapy 1

When to reassess:

• If symptoms worsen or fail to improve after 48-72 hours, consider alternative management strategies 1
• At 7 days post-diagnosis, if no improvement occurs, reassess the patient to confirm ABRS diagnosis and consider changing antibiotics 2

Common Pitfalls to Avoid

1. Don't underdose children: The standard adult formulations (500/125 mg or 875/125 mg) cannot be substituted for the pediatric ES-600 formulation, as they contain different amounts of clavulanic acid 3

2. Don't automatically extend adult therapy to 10 days: The evidence supports shorter courses in adults, and unnecessarily prolonged therapy contributes to antimicrobial resistance without improving outcomes 1, 2

3. Don't use the same duration for all conditions: These recommendations are specific to ABRS. Other conditions like protracted bacterial bronchitis may benefit from longer courses (4 weeks showed longer cough-free periods than 2 weeks) 5

Special Populations

Patients with recent antibiotic exposure or recurrent infections:

• Consider the longer end of the recommended range
• In children with AOM who had an episode in the preceding month, 10-day treatment showed better outcomes than 5-day courses 6

Administration timing:

• Give at the start of meals to minimize gastrointestinal intolerance and enhance clavulanate absorption 3